Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
Intended for Healthcare Professionals
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Debate & Analysis

Polycystic ovarian syndrome: an under-recognised problem?

Sarah C Hillman and Jeremy Dale
British Journal of General Practice 2018; 68 (670): 244. DOI: https://doi.org/10.3399/bjgp18X696101
Sarah C Hillman
Primary Care, Medical School, University of Warwick, Coventry.
Roles: Academic Clinical Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy Dale
Primary Care, Medical School, University of Warwick, Coventry.
Roles: Professor of Primary Care
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info
  • eLetters
  • PDF
Loading

Polycystic ovarian syndrome (PCOS) is a multisystem condition that can blight the course of a woman’s life. The condition is common and for many is associated with considerable distress. We argue the importance of diagnosis in what is currently an under-recognised condition.

Diagnosis of PCOS requires two of the three Rotterdam criteria to be present.1 Introducing the criteria led to an increase in PCOS prevalence from 6% to 10% in screened women of childbearing age.2 However, this is unlikely to be a true reflection of the prevalence among women who choose to consult their GP. A recent retrospective cohort study of over 2 million women in the UK reported that the prevalence of women of reproductive age with PCOS was just 1.34%, rising to 2.27% if probable cases were included.3 The authors suggested that there is significant under-diagnosis occurring, with only about 50% of women with at least two of the three criteria having a recorded diagnosis of PCOS. This might imply that GPs are attempting to avoid overmedicalisation, or it might reflect a lack of awareness. It may also indicate that it is only those women with a more severe phenotype who consult their GP.

PUTTING WOMEN IN CONTROL

We argue, not for mass screening for PCOS, but for greater awareness of the symptoms and for diagnosis of those that do present to their GP. A diagnosis of PCOS is relatively inexpensive (hormone profile and a pelvic ultrasound scan), and the current treatment of choice for women who are overweight is weight loss. Neither the investigations nor treatment have significant risks or side effects. The diagnosis can generally be undertaken in general practice, often without referral to secondary care. A diagnosis of PCOS can provide women with an understanding of their body’s metabolism and open up an important dialogue about the importance of weight loss and lifestyle. In many cases, this will encourage the long-term negative health outcomes associated with PCOS to be limited or avoided, for example, ovulation may start spontaneously following weight loss, negating the need for fertility treatment (reported as costing £1233–£1805 per woman with PCOS).4 Early identification would allow women to access fertility treatment (if required) at a younger age and hence offer a higher chance of success. Weight loss prior to conception will also impact positively on the chances of a low-risk pregnancy and delivery.

PCOS puts women at higher risk of diabetes. In making this diagnosis, women may be encouraged to potentially limit this risk with lifestyle changes and the diagnosis flags of increased surveillance. Women with PCOS are at higher risk of endometrial hyperplasia, and a diagnosis allows awareness of the importance of hormone-mediated withdrawal bleeds/intrauterine system to limit this pre- cancerous condition. Rates of depression in those with PCOS are raised, even when adjusted for BMI, family history of depression, and infertility.5 A diagnosis should be used as an opportunity to consider both physical and mental health.

There is uncertainty regarding the extent to which women will be affected by PCOS. A milder phenotype may have no long- term complications. However, conveying uncertainty is the norm for GPs and, if the diagnosis is communicated sensitively with an acknowledgment of uncertainty, women’s concerns can be addressed. Longitudinal data suggest women with PCOS have equally high levels of distress 12 months before and 12 months following the diagnosis, implying that the distress was secondary to the symptoms of PCOS rather than as a consequence of the diagnosis per se.6

A diagnosis of PCOS can be used as a catalyst for lifestyle interventions and surveillance of potential longer-term conditions, but the most important reason for offering a diagnosis is because women want to make sense of their health. Delays in making the diagnosis of PCOS is recognised as adversely affecting satisfaction with health services7 and also contributing to a woman’s distress.5 Women with PCOS consistently echo the same message: they want to understand what is happening to their bodies. The trustees from the PCOS support charity Verity relate their experience and reaction to published articles on overdiagnosis: ‘… as those who have the condition and have gone through the diagnosis process we as trustees all feel that early diagnosis and intervention would have made a significant impact on our own PCOS journeys.’8

We therefore believe the question should not be about overmedicalisation, but rather how the diagnosis is conveyed. The diagnosis should be made sensitively, promote autonomy, and so empower women to understand why their body and metabolism behave like they do, and how they can limit or reverse the effects of PCOS. They should be signposted to appropriate websites (www.verity-pcos.org.uk) for support. To not diagnose PCOS or to withhold information here would be paternalistic, unethical, unsafe, and unacceptable to women.

Notes

Provenance

Commissioned; not externally peer reviewed.

Competing interests

The authors have declared no competing interests.

  • © British Journal of General Practice 2018

REFERENCES

  1. 1.↵
    1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
    (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Bozdag G,
    2. Mumusoglu S,
    3. Zengin D,
    4. et al.
    (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12):2841–2855.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Ding T,
    2. Baio G,
    3. Hardiman PJ,
    4. et al.
    (2016) Diagnosis and management of polycystic ovary syndrome in the UK (2004–2014): a retrospective cohort study. BMJ Open 6(7):e012461.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Philips Z,
    2. Barraza-Llorens M,
    3. Posnett J
    (2000) Evaluation of the relative cost-effectiveness of treatments for infertility in the UK. Hum Reprod 15(1):95–106.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Hollinrake E,
    2. Abreu A,
    3. Maifeld M,
    4. et al.
    (2007) Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 87(6):1369–1376.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Rowlands IJ,
    2. Teede H,
    3. Lucke J,
    4. et al.
    (2016) Young women’s psychological distress after a diagnosis of polycystic ovary syndrome or endometriosis. Hum Reprod 31(9):2072–2081.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Gibson-Helm M,
    2. Teede H,
    3. Dunaif A,
    4. Dokras A
    (2017) Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 102(2):604–612.
    OpenUrlCrossRefPubMed
  8. 8.↵
    (Oct 21, 2017) Are we over-diagnosing PCOS? http://blog.verity-pcos.org.uk/2017/10/are-we-over-diagnosing-pcos (accessed 13 Mar 2018).
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 68 (670)
British Journal of General Practice
Vol. 68, Issue 670
May 2018
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Polycystic ovarian syndrome: an under-recognised problem?
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Polycystic ovarian syndrome: an under-recognised problem?
Sarah C Hillman, Jeremy Dale
British Journal of General Practice 2018; 68 (670): 244. DOI: 10.3399/bjgp18X696101

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Polycystic ovarian syndrome: an under-recognised problem?
Sarah C Hillman, Jeremy Dale
British Journal of General Practice 2018; 68 (670): 244. DOI: 10.3399/bjgp18X696101
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • PUTTING WOMEN IN CONTROL
    • Notes
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • SAFER diagnosis: a teaching system to help reduce diagnostic errors in primary care
  • An Australian reflects on the Collings report 70 years on
  • Emergencies in general practice: could checklists support teams in stressful situations?
Show more Debate & Analysis

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2022 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242